SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,427,550 | +92.9% | 307,000 | +241.2% | 0.34% | +48.3% |
| Q1 2022 | $740,000 | -92.7% | 89,980 | -86.8% | 0.23% | -89.3% |
| Q4 2021 | $10,118,000 | -0.4% | 680,000 | +26.4% | 2.15% | +13.1% |
| Q3 2021 | $10,159,000 | +10.0% | 537,800 | +8.2% | 1.90% | +23.7% |
| Q2 2021 | $9,237,000 | +18.7% | 496,900 | +45.3% | 1.53% | +34.2% |
| Q1 2021 | $7,783,000 | +11.3% | 341,950 | +6.1% | 1.14% | +25.1% |
| Q4 2020 | $6,995,000 | +376.8% | 322,200 | +120.7% | 0.91% | +218.5% |
| Q3 2020 | $1,467,000 | – | 146,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |